American Society of Clinical Oncology

Call Directions Website Contact the practice

American Society of Clinical Oncology World's leading professional organization for oncology professionals caring for people with cancer.

10/07/2026

Behind every breakthrough in oncology is an intentional team—and behind every team is a powerful story. We want to hear yours. 🩺

We’re seeking personal narratives for the ASCO Voices session at that highlight Dr. Elizabeth Mittendorf’s Presidential theme: “Intentional Teams. Exceptional Care.”

Don’t try to tell your whole story—focus on one specific patient, one tough choice, or one memory that can help inspire your global colleagues. Submit your ASCO Voices audition by November 13: https://bit.ly/4hnFkjw

Time is running out to bring your latest innovations in GU cancer research to the leading symposium of its kind and help...
10/06/2026

Time is running out to bring your latest innovations in GU cancer research to the leading symposium of its kind and help optimize patient outcomes. By sharing your insights, you can directly contribute to the evolution of patient-centered care and spark meaningful global collaborations.

Submit your abstract for by the October 13 at 11:59 PM (ET): https://bit.ly/4d3xlWa

Co-sponsors: Society of Urologic Oncology and American Society for Radiation Oncology

Applications are now open for the International Clinical Research Scholars (ICRS) Program - Africa! In partnership with ...
10/05/2026

Applications are now open for the International Clinical Research Scholars (ICRS) Program - Africa! In partnership with African Organisation for Research and Training in Cancer, this 1-year hybrid program combines hands-on clinical research training with personalized mentorship. Bring your research idea, sharpen your investigation skills, and improve care in your community while connecting with peers and mentors across the region. Deadline: December 1, 2026.

Apply now: https://bit.ly/4xVcT1k

Applications for the Career Development Award (CDA) close on October 8, 2026, at 11:59 PM (ET).Secure the mentored fundi...
10/05/2026

Applications for the Career Development Award (CDA) close on October 8, 2026, at 11:59 PM (ET).
Secure the mentored funding you need to establish your independent clinical cancer research program.

Don't let this opportunity pass you by—submit your application to Conquer Cancer Foundation today: https://bit.ly/4d1u5e6

Your expertise matters. Our draft guideline protocol for “Treatment of Metastatic Colorectal Cancer: ASCO Guideline Upda...
10/02/2026

Your expertise matters. Our draft guideline protocol for “Treatment of Metastatic Colorectal Cancer: ASCO Guideline Update” is now available for open comment.

Open comment is a critical step in our development process, ensuring transparency and clinical excellence. Review the protocol and share your feedback to help shape the future of survivorship care by October 16.

Read and comment here: https://bit.ly/4rCADFR

We are proud to announce Dr. Areej R. El-Jawahri as the recipient of the prestigious 2026 Joseph Simone Quality Care Awa...
10/02/2026

We are proud to announce Dr. Areej R. El-Jawahri as the recipient of the prestigious 2026 Joseph Simone Quality Care Award! 🏆

As co-director of the Cancer Outcomes Research and Education Program (CORE) at Massachusetts General Hospital, Dr. El-Jawahri has spent her career transforming supportive and palliative care for patients with hematologic malignancies. Her clinical trials and patient-centered research represent the exact spirit of safety, compassion, and innovation this award celebrates.

Join us in honoring her and tuning into her keynote lecture at the upcoming 2026 ASCO Quality Care Symposium. Learn more about her dedication to finding purpose in every aspect of oncology: https://bit.ly/4ypiCh1

We just released a living guideline update for Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer.W...
10/01/2026

We just released a living guideline update for Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer.

What’s new? This update specifically addresses first-line recommendations for patients with HER2-positive gastroesophageal carcinoma.

Key Updated Recommendations:
💠 pMMR/MSS with PD-L1 ≥1: Treatment with a HER2-targeting antibody plus immunotherapy should be offered, in combination with fluoropyrimidine and platinum-based chemotherapy.
💠pMMR/MSS with PD-L1

Developing sustainable palliative care services requires targeted training and strong professional networks. Through ASC...
10/01/2026

Developing sustainable palliative care services requires targeted training and strong professional networks.

Through ASCO's International Palliative Care Education Collaboration, your health organization can build up local "Train the Trainer" champions, access virtual introductory programs, and participate in an advanced in-person course led by global experts.
Submit your proposal before the November 30th deadline to bring this multi-year collaboration to your community!

🔗 Get started: https://bit.ly/4rCaQOk

We just released a living guideline update for Therapy for Stage IV Non-Small Cell Lung Cancer with Driver Alterations.W...
09/30/2026

We just released a living guideline update for Therapy for Stage IV Non-Small Cell Lung Cancer with Driver Alterations.

What’s new? This update provides revised recommendations for first-line treatment of patients with EGFR exon 20 insertions, clinicians should offer sunvozertinib monotherapy, or combination treatment with platinum doublet chemotherapy plus amivantamab.

Read the updated guideline and review the full recommendations: https://bit.ly/4AxH7d7

ASCO and the World Health Organization (WHO) have formally signed a collaboration agreement to address challenges in acc...
09/28/2026

ASCO and the World Health Organization (WHO) have formally signed a collaboration agreement to address challenges in accessing quality cancer care internationally.

Cancer remains a leading cause of morbidity and mortality worldwide, with the highest health, social, and economic burdens falling on low- and middle-income countries.

To support governments in implementing programs that improve access and survival, this landmark agreement prioritizes three key areas:
1️⃣ Capacity building in core health professional competencies.
2️⃣ Improving access to cancer clinical trials.
3️⃣ Strengthening quality, accessibility, and accountability in cancer care.

Read the official announcement to learn more about this collaboration agreement: https://bit.ly/4hiGpJs

Address

2318 Mill Road, Ste 800
Alexandria, VA
22314

Telephone

+17032990150

Website

Alerts

Be the first to know and let us send you an email when American Society of Clinical Oncology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to American Society of Clinical Oncology:

Shortcuts

Share

Category